Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Aurelie Collignon"'
Autor:
Jerome Galon, Jacques Fieschi, Aurelie Collignon, Alex Trinh, Marion Olive, Maïté Chamourin, Alboukadel Kassambara, Lucie Sudre, Anthony Lebret, Giovanni Bussoti
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/d2d9298d5c7240a39def59423ac5341c
Autor:
Jerome Galon, Aurelie Collignon, Alex Trinh, Marion Olive, Clémence Jaume, Maïté Chamourin, Nour Sfeir, Dylan Anselmo, Raana Ramouz-Charpentier, Georgia Culey, Christophe Haond, Jacques Fieschi-Meric
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/ce515bad97d34972b4d29e0d2c75c7e6
Autor:
Jerome Galon, Aurelie Collignon, Alex Trinh, Marion Olive, Clémence Jaume, Maïté Chamourin, Nour Sfeir, Dylan Anselmo, Raana Ramouz-Charpentier, Georgia Culey, Christophe Haond, Jacques Fieschi-Meric
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/b86738bfef834e5cb4e5ab9c3d5b6147
Autor:
Aurelie Collignon, Alboukadel Kassambara, Alex Trinh, Maité Chamourin, Georgia Culley, Marion Olive, Clemence Jaume, Assil Benchaaben, Jerome Galon, Jacques Fieschi
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Carole Siret, Aurélie Collignon, Françoise Silvy, Stéphane Robert, Thierry Cheyrol, Perrine André, Véronique Rigot, Juan Iovanna, Serge van de Pavert, Dominique Lombardo, Eric Mas, Anna Martirosyan
Publikováno v:
Frontiers in Immunology, Vol 10 (2020)
Pancreatic ductal adenocarcinoma (PDAC) is a fatal disease with rising incidence and a remarkable resistance to current therapies. The reasons for this therapeutic failure include the tumor's extensive infiltration by immunosuppressive cells such as
Externí odkaz:
https://doaj.org/article/521dadb697b543e381156702c22814fb
Autor:
Aurélie Collignon, Françoise Silvy, Stéphane Robert, Malika Trad, Sébastien Germain, Jérémy Nigri, Frédéric André, Véronique Rigot, Richard Tomasini, Bernard Bonnotte, Dominique Lombardo, Eric Mas, Evelyne Beraud
Publikováno v:
OncoImmunology, Vol 7, Iss 12 (2018)
Pancreatic adenocarcinoma (PAC) has a poor prognosis. One treatment approach, investigated here, is to reinforce antitumor immunity. Dendritic cells (DCs) are essential for the development and regulation of adaptive host immune responses against tumo
Externí odkaz:
https://doaj.org/article/64caf32902694b35a6197ca1d25f0fab